共 7 条
- [4] Clinical–Diffusion Mismatch and Benefit From Thrombolysis 3 to 6 Hours After Acute Stroke[J] . Martin Ebinger,Takeshi Iwanaga,Jane F. Prosser,Deidre A. De Silva,Soren Christensen,Marnie Collins,Mark W. Parsons,Christopher R. Levi,Christopher F. Bladin,P Alan Barber,Geoffrey A. Donnan,Stephen M. Davis.Stroke . 2009 (7)
- [5] Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of Safety and Efficacy 3 to 9 Hours After Stroke Onset[J] . Anthony J. Furlan,Dirk Eyding,Gregory W. Albers,Yasir Al-Rawi,Kennedy R. Lees,Howard A. Rowley,Christian Sachara,Mariola Soehngen,Steven Warach,Werner Hacke.Stroke . 2006 (5)
- [7] The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A Phase II MRI-Based 9-Hour Window Acute Stroke Thrombolysis Trial With Intravenous Desmoteplase[J] . Werner Hacke,Greg Albers,Yasir Al-Rawi,Julien Bogousslavsky,Antonio Davalos,Michael Eliasziw,Michael Fischer,Anthony Furlan,Markku Kaste,Kennedy R. Lees,Mariola Soehngen,Steven Warach.Stroke . 2005 (1)